The only issue with ILA is when is the Phase 2 trial going to start.
It was originally this quarter. Then next quarter.
From the quarterly : "Island is collaborating with the State University of New York (SUNY) Upstate in Syracuse for
the ISLA-101 Phase II Clinical Trial. The Company has maintained frequent communication
with collaborators at SUNY Upstate to continue planning for the dengue human infection
model (DHIM) Phase 2 clinical trial and is currently working towards completion of a Clinical
Trial agreement. An update on this agreement is expected shortly."
The only issue with ILA is when is the Phase 2 trial going to...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
